As of 2024-12-15, the Fair Value of Isracann Biosciences Inc (IPOT.CN) is -0.13 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.02 CAD, the upside of Isracann Biosciences Inc is -963.67%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-05-31 | 2019-05-31 | 2020-05-31 | 2021-05-31 | 2022-05-31 | 5Y Avg | |
| Net income | -7.47 | -9.90 | -24.20 | -25.16 | -4.69 | -14.29 |
| YoY growth | -1,018.58% | -32.50% | -144.36% | -3.94% | 81.34% | -223.61% |
| Market Cap (mil) | 2.63 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | -223.61% |
| TTM earnings | -4.54 |